financetom
Business
financetom
/
Business
/
Nuvalent Launches $350 Million Common Stock Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nuvalent Launches $350 Million Common Stock Offering
Sep 16, 2024 9:28 AM

08:05 AM EDT, 09/16/2024 (MT Newswires) -- Nuvalent ( NUVL ) said Monday it has launched an underwritten public offering of $350 million of its shares of Class A common stock.

The company expects to grant the underwriters a 30-day option to buy up to an additional 15% of shares sold in the offering.

Nuvalent's ( NUVL ) shares jumped nearly 19% in recent Monday premarket activity.

Price: 104.00, Change: +16.55, Percent Change: +18.93

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BMO On The Day Ahead In Canada
BMO On The Day Ahead In Canada
Mar 26, 2026
07:38 AM EDT, 03/26/2026 (MT Newswires) -- Canada will release the Survey of Employment, Payrolls and Hours (SEPH) for January at 8:30 a.m. ET on Thursday, said Bank of Montreal (BMO). The payroll survey can be used to corroborate the softness in the more timely Labour Force Survey (LFS) to start the year, noted the bank. BMO also sees job...
Stack Capital Group Upsizes Financing To C$30 Million From C$15 Million
Stack Capital Group Upsizes Financing To C$30 Million From C$15 Million
Mar 26, 2026
07:44 AM EDT, 03/26/2026 (MT Newswires) -- Stack Capital Group ( STCGF ) said Thursday that it has upsized it previously announced best efforts private placement to C$30 million from $15 million, citing strong investor demand. The financing comprises 1,133,334 units priced at $18.75 apiece for up to $21.25 million in proceeds in a concurrent private placement, as well as...
Tonix Pharmaceuticals Doses First Participant in Potential Migraine Treatment Study
Tonix Pharmaceuticals Doses First Participant in Potential Migraine Treatment Study
Mar 26, 2026
07:40 AM EDT, 03/26/2026 (MT Newswires) -- Tonix Pharmaceuticals ( TNXP ) said Thursday the first participant has been dosed in a phase 1 study of TNX-1900 to assess its potential for treating migraine and craniofacial pain. The study will help evaluate the effect of the TNX-1900 intranasal potentiated oxytocin on trigeminal nerve-mediated vasodilation of the forehead using capsaicin, as...
Market Chatter: UBS, Deutsche Bank Working on First Central Group's Potential UK IPO
Market Chatter: UBS, Deutsche Bank Working on First Central Group's Potential UK IPO
Mar 26, 2026
07:41 AM EDT, 03/26/2026 (MT Newswires) -- UBS Group ( UBS ) and Deutsche Bank ( DB ) are working on First Central Group's potential initial public offering in the UK, Bloomberg reported Thursday, citing sources familiar with the matter. Sources told Bloomberg that First Central also signed Fenchurch Advisory Partners as financial adviser for the IPO and that the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved